Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



French and Italians ink global cranberry supplements deal

By Shane Starling , 21-Oct-2013
Last updated on 22-Oct-2013 at 10:29 GMT2013-10-22T10:29:27Z

Japan will be first port of call in new Indena-Pharmatoka cranberry partnership
Japan will be first port of call in new Indena-Pharmatoka cranberry partnership

Italian botanicals giant Indena will market a high-potency cranberry extract made by French firm Pharmatoka in global markets like South Korea, India and Russia, under a new alliance.

The deal will see Indena manufacture and market Pharmatoka’s Gikacran extract, 200g of which contains 36mg of the active proanthocyanidin (PAC) components which have been linked to urinary tract infection (UTI) benefits in women.

Japan and China will also feature.

We are excited to start the commercialization of Gikacran in these countries in which we have an historical important presence, and Japan is the first market we will approach,” said Christian Artaria, Indena marketing director.

“We strongly believe in Gikacran and in its potential, and we are really confident that our product will clearly distinguish from any other cranberry extract on the market”.

Gikacran has appeared in Pharmatoka products Urell and Ellura.

Gunter Haesaerts, CEO and founder of Pharmatoka, added: “Indena and Pharmatoka share the mission to improve health and well-being for people worldwide, summarized in our four principles: Scientific support, close relationship with health professionals, continuous listening to our customers and excellence of our products are what we commit to, and Indena is an excellent partner.”


Gikacran is approved in Malaysia as a traditional herbal medicine and in Australia as a complementary listed medicine. It has not won approval for UTI benefits in the European Union despite a claim formerly existing in France and several applications from Pharmatoka and other players like Ocean Spray.

However claims have been won under EU medical devices law.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars